Received Dec 31, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
suffering severe hives everyday; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of hives in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced hives (Verbatim: suffering severe hives everyday). The outcome of the hives was not resolved. It was unknown if the reporter considered the hives to be related to Shingrix. It was unknown if the company considered the hives to be related to Shingrix. Additional Information: GSK Receipt Date: 28-DEC-2025 This case was reported by a patient via interactive digital media. The patient had a Shingrix shot a couple of months ago and has been experiencing severe hives every day since. The batch number was not provided, and we are unable to contact the reporter.